These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11304439)

  • 1. Persistent subclinical inflammation among A-bomb survivors.
    Neriishi K; Nakashima E; Delongchamp RR
    Int J Radiat Biol; 2001 Apr; 77(4):475-82. PubMed ID: 11304439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold.
    Neriishi K; Nakashima E; Minamoto A; Fujiwara S; Akahoshi M; Mishima HK; Kitaoka T; Shore RE
    Radiat Res; 2007 Oct; 168(4):404-8. PubMed ID: 17903036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors.
    Hayashi T; Morishita Y; Kubo Y; Kusunoki Y; Hayashi I; Kasagi F; Hakoda M; Kyoizumi S; Nakachi K
    Am J Med; 2005 Jan; 118(1):83-6. PubMed ID: 15639214
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985.
    Yoshimoto Y; Ezaki H; Etoh R; Hiraoka T; Akiba S
    Radiat Res; 1995 Mar; 141(3):278-86. PubMed ID: 7871154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of five anthropometric measurements at age 18 to radiation dose among atomic bomb survivors exposed in utero.
    Nakashima E
    Radiat Res; 1994 Apr; 138(1):121-6. PubMed ID: 8146291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell immunosenescence and inflammatory response in atomic bomb survivors.
    Kusunoki Y; Yamaoka M; Kubo Y; Hayashi T; Kasagi F; Douple EB; Nakachi K
    Radiat Res; 2010 Dec; 174(6):870-6. PubMed ID: 21128811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects.
    Suit H; Goldberg S; Niemierko A; Ancukiewicz M; Hall E; Goitein M; Wong W; Paganetti H
    Radiat Res; 2007 Jan; 167(1):12-42. PubMed ID: 17214511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
    Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
    Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to ionizing radiation in adulthood and thyroid cancer incidence.
    Richardson DB
    Epidemiology; 2009 Mar; 20(2):181-7. PubMed ID: 19177023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual variation of somatic gene mutability in relation to cancer susceptibility: prospective study on erythrocyte glycophorin a gene mutations of atomic bomb survivors.
    Kyoizumi S; Kusunoki Y; Hayashi T; Hakoda M; Cologne JB; Nakachi K
    Cancer Res; 2005 Jun; 65(12):5462-9. PubMed ID: 15958596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose survival of G0 lymphocytes irradiated in vitro: a test for a possible population bias in the cohort of atomic bomb survivors exposed to high doses.
    Nakamura N; Sposto R; Akiyama M
    Radiat Res; 1993 Jun; 134(3):316-22. PubMed ID: 8316624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of dementia among atomic-bomb survivors--Radiation Effects Research Foundation Adult Health Study.
    Yamada M; Kasagi F; Mimori Y; Miyachi T; Ohshita T; Sasaki H
    J Neurol Sci; 2009 Jun; 281(1-2):11-4. PubMed ID: 19327783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors.
    Lagarde F
    Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic blood pressure and systolic hypertension in adolescence of atomic bomb survivors exposed in utero.
    Nakashima E; Akahoshi M; Neriishi K; Fujiwara S
    Radiat Res; 2007 Nov; 168(5):593-9. PubMed ID: 17973553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study.
    Yamada M; Naito K; Kasagi F; Masunari N; Suzuki G
    Int J Radiat Biol; 2005 Nov; 81(11):821-6. PubMed ID: 16484151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataract in atomic bomb survivors.
    Minamoto A; Taniguchi H; Yoshitani N; Mukai S; Yokoyama T; Kumagami T; Tsuda Y; Mishima HK; Amemiya T; Nakashima E; Neriishi K; Hida A; Fujiwara S; Suzuki G; Akahoshi M
    Int J Radiat Biol; 2004 May; 80(5):339-45. PubMed ID: 15223766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.